Patricia Treble is the royal specialist at Maclean’s. In addition to her interest in all things monarchical—from the Queen's ...
The drug regulator has cleared Serum Institute to begin Phase III trials for a 2-in-1 covid-flu vaccine while simultaneously approving an Omicron-specific booster, marking a transition toward seasonal ...
March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle a long-running legal fight over the ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia have demonstrated that an intranasal vaccine booster may confer ...
Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...
Separate VSD analyses confirmed no increased risk of all-cause mortality, cardiac mortality, or non-COVID mortality in the 28 ...
As the midterm elections approach, the health secretary is focusing on “real food.” Anger is rising among some of his supporters.
Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to ...
According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...
European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...
In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results